We’re focusing on patent and intellectual property issues in international agreements and national laws. Some of the major issues we're tackling are:
Keeping the ‘pharmacy of the developing world’ open
MSF relies heavily on Indian generic medicines for the treatment of HIV, tuberculosis (TB), malaria and other infectious diseases. But India is under attack from the US, the EU, Japan and others who are protecting multinational pharmaceutical profits over peoples’ lives.
With the #HandsOffOurMeds campaign, MSF is urging India to maintain its intellectual property policies, including patent laws, that place people’s lives above pharmaceutical profits, in the interest of public health.